Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model
Authors:
- Sofia Mickaela MartinezSMSofia Mickaela Martinez
- Ayelen IndaAIAyelen Inda
- Maximiliano Nicolás RíosMRMaximiliano Nicolás Ríos
- Carolina del Valle BessoneCBCarolina del Valle Bessone
- Abril Bruera BossioABAbril Bruera Bossio
- Mario Eduardo GuidoMario Eduardo Guido
- José Domingo Luna PintoJPJosé Domingo Luna Pinto
- Daniel Alberto AllemandiDADaniel Alberto Allemandi
- Daniela Alejandra QuinterosDaniela Alejandra Quinteros
Open Access
- 10 January 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (1) , 85
Abstract
Background/Objectives: Neurodegenerative ocular diseases, such as age-related macular degeneration (AMD) and glaucoma, represent growing public health concerns. Oxidative stress plays a key role in their development, damaging retinal cells and accelerating disease progression. Melatonin (Mel) is a potent antioxidant with neuroprotective properties; however, it faces limitations such as low solubility. This study proposes the use of human serum albumin nanoparticles (Np-HSA) to enhance the delivery of Mel to the posterior segment of the eye and evaluates its neuroprotective and anti-apoptotic effects on the retina. Methods: A model of retinal degeneration was induced in New Zealand albino rabbits using cytotoxic and oxidative agents. Np-HSA-Mel nanoparticles were administered subconjunctivally, and cellular viability and retinal functionality were assessed using flow cytometry and pupillary light reflex (PLR). Histological and immunohistochemical studies, including the TUNEL assay, were performed to analyse cell survival and apoptotic index. Results: Np-HSA-Mel significantly preserved pupillary function and cell viability, demonstrating lower apoptosis compared to Mel solution and Np-HSA alone. Histologically, eyes treated with Np-HSA-Mel exhibited fewer structural alterations and greater cellular organisation. The TUNEL assay confirmed a significant reduction in the apoptotic index of retinal ganglion cells (RGCs) treated with Np-HSA-Mel. Conclusions: Np-HSA-Mel effectively overcame ocular barriers, achieving greater neuroprotective efficacy at the retinal level. These findings highlight the synergistic potential of albumin and Mel in treating neurodegenerative ocular diseases, opening new perspectives for future therapies.Keywords
Funding Information
- Consejo Nacional de Investigaciones Científicas y Técnicas (PIP 2022-2024-GI, PICT-2021-I-A-01195)
- Fondo para la Investigación Científica y Tecnológica (PIP 2022-2024-GI, PICT-2021-I-A-01195)
This publication has 41 references indexed in Scilit:
- New RP-HPLC method for the simultaneous determination of process yield and percentage of encapsulation of Gallein in albumin nanoparticlesJournal of Chromatography B, 2024
- Small extracellular vesicles: Yields, functionalization and applications in diabetic wound managementInterdisciplinary Medicine, 2023
- Development of melatonin-loaded, human-serum-albumin nanoparticles formulations using different methods of preparation for ophthalmic administrationInternational Journal of Pharmaceutics, 2022
- An in vivo zebrafish model reveals circulating tumor cell targeting capacity of serum albumin nanoparticlesJournal of Drug Delivery Science and Technology, 2022
- Tailoring dexamethasone loaded albumin nanoparticles: A full factorial design with enhanced anti-inflammatory activity In vivoJournal of Drug Delivery Science and Technology, 2022
- Telomeres: history, health, and hallmarks of agingCell, 2021
- Neuroprotective effect of melatonin loaded in ethylcellulose nanoparticles applied topically in a retinal degeneration model in rabbitsExperimental Eye Research, 2020
- Albumin-based nanoparticles as potential controlled release drug delivery systemsJournal of Controlled Release, 2012
- Mucoadhesive curcumin nanospheres: Biological activity, adhesion to stomach mucosa and release of curcumin into the circulationJournal of Controlled Release, 2011
- Concentration of Gentamicin in Experimental Corneal UlcersArchives of Ophthalmology (1950), 1974